肿瘤免疫研课程班.pptx
上传人:骑着****猪猪 上传时间:2024-09-14 格式:PPTX 页数:78 大小:37.5MB 金币:20 举报 版权申诉
预览加载中,请您耐心等待几秒...

肿瘤免疫研课程班.pptx

肿瘤免疫研课程班.pptx

预览

免费试读已结束,剩余 68 页请下载文档后查看

20 金币

下载此文档

如果您无法下载资料,请参考说明:

1、部分资料下载需要金币,请确保您的账户上有足够的金币

2、已购买过的文档,再次下载不重复扣费

3、资料包下载后请先用软件解压,在使用对应软件打开

会计学Modelofsequentialgeneticalterationsleadingtometastaticcoloncancer.Eachofthestagesindicatedatthebottomismorphologicallydistinct,allowingresearcherstodeterminethesequenceofgeneticalterations.一、肿瘤特异性抗原二、肿瘤相关性抗原化学和物理致癌因素诱发的肿瘤抗原病毒诱发的肿瘤抗原癌基因和突变型抑癌基因表达的肿瘤抗原正常静止基因表达的肿瘤抗原Micewereinducedtoproducetumorsbytheinjectionofachemicalcarcinogen(methyl-cholanthrene).Tumorcellsfromthesemiceweretheninjectedsubcutaneouslyintogeneticallyidenticalmice.Later,thegrowingtumorwereremovedsurgically.Micechallengedwiththesametumorwereabletorejectit,butthosechallengedwithadifferenttumor(inducedwiththesamecarcinogen)werenot.Theabilitytorejectthetumorcouldbetransferredwithlymphoidcells.Experimentalinductionofimmunityagainsttumorcellsinducedbypolyomavirus(PV)癌基因和突变型抑癌基因表达的肿瘤抗原Activationofagrowthfactorreceptorinvolvesligandbinding,dimerization,andautophosphorylation,Atruncatedoncogenicreceptorthatlackstheligand-bindingregionisconstitutivelyactivebecauseitisnotrepressedbytheN-terminaldomain.Translocationsbetweenchromosome22andchromosome9generatePhiladephiachromosomesthatsynthesizebcl-ablfusiontranscriptsthatareresponsiblefortwotypesofleukemia.AlterationFunctionofproteinTumortypePointmutationERBB2GrowthfactorreceptorBreastcarcinomaFMSCSF-1receptorAML,myelodysplasiaRasGTP-bindingproteinCarcinomasandothersp53TumorsuppressorcellcyclecontrolManyincludingbladder,colon,lungRB1TumorsuppressorcellcyclecontrolRetinoblastoma,osteosarcomaPancreaticcarcinomaChromosomaltranslocationBCR-ABLTyrosinekinaseCML,ALLEZA-PRLTranscriptionfactorPre-BcellALLH4-RETGrowthfactorreceptor/tyrosinekinaseThyroidcarcinomaTPR-METGrowthfactorreceptor/tyrosinekinaseGastriccarcinomaLMYC-RLFTranscriptionfactorSmallcelllungcarcinomaNPM/ALKTyrosinekinaseLymphomaDeletionmutationsERB-BGrowthfactorreceptorGlimasTumourantigensrecognizedbyTlymphocytes:atthecoreofcancerimmunotherapy.NATUREREVIEWS|CANCERVOLUME14|FEBRUARY2014ImmunogenicityofNY-ESO-1,MAGE-A1,MAGE-A3,andSSX-2CTantigenmRNAE